Cutting edge: Rapid boosting of cross-reactive memory CD8 T cells broadens the protective capacity of the flumist vaccine

Journal of Immunology

Volumn 190, Issue 8, 2013, Pages 3854-3858

  Slütter, Bram ^a   Pewe, Lecia L ^a   Lauer, Peter ^b   Harty, John T ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b Aduro BioTech Inc   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; FEMALE; INFLUENZA A; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; TIME FACTORS;

EID: 84875967881     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202790     Document Type: Article

References (28)

1. Molinari, N. A., I. R. Ortega-Sanchez, M. L. Messonnier, W. W. Thompson, P. M. Wortley, E. Weintraub, and C. B. Bridges. 2007. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25: 5086-5096.
2. Osterholm, M. T., N. S. Kelley, A. Sommer, and E. A. Belongia. 2012. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect. Dis. 12: 36-44.
3. Heiny, A. T., O. Miotto, K. N. Srinivasan, A. M. Khan, G. L. Zhang, V. Brusic, T. W. Tan, and J. T. August. 2007. Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLoS ONE 2: e1190.
4. Hoft, D. F., E. Babusis, S. Worku, C. T. Spencer, K. Lottenbach, S. M. Truscott, G. Abate, I. G. Sakala, K. M. Edwards, C. B. Creech, et al. 2011. Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J. Infect. Dis. 204: 845-853.
5. Lanthier, P. A., G. E. Huston, A. Moquin, S. M. Eaton, F. M. Szaba, L. W. Kummer, M. P. Tighe, J. E. Kohlmeier, P. J. Blair, M. Broderick, et al. 2011. Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses. Vaccine 29: 7849-7856.
6. Sinnathamby, G., P. Lauer, J. Zerfass, B. Hanson, A. Karabudak, J. Krakover, A. A. Secord, T. M. Clay, M. A. Morse, T. W. Dubensky, Jr., et al. 2009. Priming and activation of human ovarian and breast cancer-specific CD8+ T cells by polyvalent Listeria monocytogenes-based vaccines. J. Immunother. 32: 856-869.
7. Iida, T., and F. B. Bang. 1963. Infection of the upper respiratory tract of mice with influenza A virus. Am. J. Hyg. 77: 169-176.
8. Legge, K. L., and T. J. Braciale. 2005. Lymph node dendritic cells control CD8+ T cell responses through regulated FasL expression. Immunity 23: 649-659.
9. Jang, Y. H., Y. H. Byun, Y. J. Lee, Y. H. Lee, K. H. Lee, and B. L. Seong. 2012. Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses. J. Virol. 86: 5953-5958.
10. Christensen, J. P., P. C. Doherty, K. C. Branum, and J. M. Riberdy. 2000. Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory. J. Virol. 74: 11690-11696.
11. Woodland, D. L. 2004. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol. 25: 98-104.
12. Lakhashe, S. K., V. Velu, G. Sciaranghella, N. B. Siddappa, J. M. Dipasquale, G. Hemashettar, J. K. Yoon, R. A. Rasmussen, F. Yang, S. J. Lee, et al. 2011. Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges. Vaccine 29: 5611-5622.
13. Le, D. T., D. G. Brockstedt, R. Nir-Paz, J. Hampl, S. Mathur, J. Nemunaitis, D. H. Sterman, R. Hassan, E. Lutz, B. Moyer, et al. 2012. A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction. Clin. Cancer Res. 18: 858-868.
14. Sanchez, P. J., J. A. McWilliams, C. Haluszczak, H. Yagita, and R. M. Kedl. 2007. Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J. Immunol. 178: 1564-1572.
15. Wirth, T. C., J. T. Harty, and V. P. Badovinac. 2010. Modulating numbers and phenotype of CD8+ T cells in secondary immune responses. Eur. J. Immunol. 40: 1916-1926.
16. Xiao, Z., K. A. Casey, S. C. Jameson, J. M. Curtsinger, and M. F. Mescher. 2009. Programming for CD8 T cell memory development requires IL-12 or type I IFN. J. Immunol. 182: 2786-2794.
17. Joshi, N. S., W. Cui, A. Chandele, H. K. Lee, D. R. Urso, J. Hagman, L. Gapin, and S. M. Kaech. 2007. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
18. Sarkar, S., V. Kalia, W. N. Haining, B. T. Konieczny, S. Subramaniam, and R. Ahmed. 2008. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205: 625-640.
19. Zweerink, H. J., S. A. Courtneidge, J. J. Skehel, M. J. Crumpton, and B. A. Askonas. 1977. Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses. Nature 267: 354-356.
20. Dormitzer, P. R., G. Galli, F. Castellino, H. Golding, S. Khurana, G. Del Giudice, and R. Rappuoli. 2011. Influenza vaccine immunology. Immunol. Rev. 239: 167-177.
21. Carter, N. J., and M. P. Curran. 2011. Live attenuated influenza vaccine (Flu-Mist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults. Drugs 71: 1591-1622.
22. Forrest, B. D., A. D. Steele, L. Hiemstra, R. Rappaport, C. S. Ambrose, and W. C. Gruber. 2011. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older. Vaccine 29: 3633-3639.
23. Bodewes, R., P. L. Fraaij, J. H. Kreijtz, M. M. Geelhoed-Mieras, R. A. Fouchier, A. D. Osterhaus, and G. F. Rimmelzwaan. 2012. Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine 30: 7407-7410.
24. Bodewes, R., P. L. Fraaij, M. M. Geelhoed-Mieras, C. A. van Baalen, H. A Tiddens, A. M. van Rossum, F. R. van der Klis, R. A. Fouchier, A. D. Osterhaus, and G. F. Rimmelzwaan. 2011. Annual vaccination against influenza virus hampers development of virus-specific CD8 T cell immunity in children. J. Virol. 85: 11995-12000.
25. Bridle, B. W., J. E. Boudreau, B. D. Lichty, J. Brunellière, K. Stephenson, S. Koshy, J. L. Bramson, and Y. Wan. 2009. Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus. Mol Ther. 17: 1814-1821.
26. Badovinac, V. P., K. A. Messingham, A. Jabbari, J. S. Haring, and J. T. Harty. 2005. Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 11: 748-756.
27. Keppler, S. J., K. Rosenits, T. Koegl, S. Vucikuja, and P. Aichele. 2012. Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses. PLoS ONE 7: e40865.
28. Berthoud, T. K., M. Hamill, P. J. Lillie, L. Hwenda, K. A. Collins, K. J. Ewer, A. Milicic, H. C. Poyntz, T. Lambe, H. A. Fletcher, et al. 2011. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin. Infect. Dis. 52: 1-7.